Neoflow Technologies
About
What does Neoflow Technologies do?
Neoflow Technologies Ltd. is a medical device startup focused on developing a novel endovascular solution for the treatment of vasospasm, a critical complication of aneurysmal subarachnoid hemorrhage (aSAH). Vasospasm can lead to delayed ischemic neurological deficit (DIND), a major cause of morbidity and mortality in aSAH patients.
What is Neoflow Technologies's revenue?
StartupHub estimates Neoflow Technologies's annual revenue at $5.4M (range $1.5M to $10.8M, 31% confidence), based on comparable companies in the sector.
What is Neoflow Technologies's valuation?
StartupHub estimates Neoflow Technologies's effective valuation at $38.6M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Neoflow Technologies raised?
Neoflow Technologies has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Neoflow Technologies headquartered?
Neoflow Technologies is headquartered in Tel Aviv, Israel.
When was Neoflow Technologies founded?
Neoflow Technologies was founded in 2022.
What industry does Neoflow Technologies operate in?
Neoflow Technologies operates in Healthcare, Medical Device, MedTech, HealthTech, Biotechnology, Drug Discovery.
What is Neoflow Technologies's current status?
Neoflow Technologies's current operating status is: Inactive.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.